CIK 0001776111 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MBX Biosciences, Inc.
Sign in to watch- Ticker
- MBX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 3179893100
- Business address
- 11711 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46032
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $288,361
- in 2 filings
Net −$288,361. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Hoerter Steven L. Chairman, President and CEO | Sale | −4,893 | $54.82 | $268K | 78,045 |
| 2026-11-04 | Azoulay Salomon Chief Medical Officer | Sale | −373 | $53.96 | $20K | 14,026 |
| 2026-10-20 | Radovich Peter Director | Grant or award · Stock option (right to buy) | +18,200 | 18,200 | ||
| 2026-08-04 | Azoulay Salomon Chief Medical Officer | Sale | −370 | $65.77 | $24K | 14,399 |
| 2026-08-03 | Smither John W Chief Financial Officer | Grant or award | +28,000 | 28,000 | ||
| 2026-08-03 | Smither John W Chief Financial Officer | Grant or award · Stock option (right to buy) | +130,000 | 130,000 | ||
| 2026-08-03 | Hoerter Steven L. President and CEO | Grant or award | +71,000 | 82,938 | ||
| 2026-08-03 | Hoerter Steven L. President and CEO | Grant or award · Stock option (right to buy) | +331,000 | 331,000 | ||
| 2026-06-04 | Mathers Edward T Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2026-06-04 | Pescovitz Ora H. Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2026-06-04 | Heron Patrick J Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2026-06-04 | Stelzer Laurie Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2026-06-04 | Hoerter Steven L. Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2026-06-04 | Ryder Steven Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2026-06-04 | Aynechi Tiba Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2026-05-08 | Azoulay Salomon Chief Medical Officer | Option exercise 10b5-1 | +55,000 | $10.46 | $575K | 69,769 |
| 2026-05-08 | Azoulay Salomon Chief Medical Officer | Sale 10b5-1 | −55,000 | $38.38 | $2.1M | 14,769 |
| 2026-05-08 | Azoulay Salomon Chief Medical Officer | Option exercise 10b5-1 | +15,003 | $16.00 | $240K | 29,772 |
| 2026-05-08 | Azoulay Salomon Chief Medical Officer | Sale 10b5-1 | −15,003 | $38.30 | $575K | 14,769 |
| 2026-05-08 | Azoulay Salomon Chief Medical Officer | Option exercise · Stock option (right to buy) 10b5-1 | +55,000 | 194,540 |
Page 1 of 9 · 164 trades